PERSONALISED MEDICINE: In 2018, an estimated 40% of new drugs approved by the FDA were considered personalised medicines; this is expected to exceed 50% this year.

Marc Buchet

Jan. 14, 2020

SCIENTIFIC

PERSONALISED MEDICINE: In 2018, an estimated 40% of new drugs approved by the FDA were considered personalised medicines; this is expected to exceed 50% this year.

 

Pharma Precision Medicine Readiness Report 2019 -

Diaceutics 2019 https://www.diaceutics.com/

50% of eligible cancer patients are missing out on potentially life-saving drugs due to the broken diagnostic testing ecosystem.

Industry Experts at Diaceutics reveal insights and solutions to the current state of affairs in the 6th Annual PM Readiness Report.

Access Report